EDITORIALS

Treatment of Advanced Non–Small-Cell Lung Cancer With Two-Drug Combinations

Paul A. Bunn, Jr

JCO Sep 1 2002: 3565–3567. [Full Text] [PDF]

Imatinib GIST Keeps Finding New Indications: Successful Treatment of Dermatofibrosarcoma Protuberans by Targeted Inhibition of the Platelet-Derived Growth Factor Receptor

Charles L. Sawyers

JCO Sep 1 2002: 3568–3569. [Full Text] [PDF]

Diet and Trend in Prostate-Specific Antigen: Inferences for Prostate Cancer Risk

Alan R. Kristal

JCO Sep 1 2002: 3570–3571. [Full Text] [PDF]

Size of the Androgen Receptor CAG Repeat and Prostate Cancer: Does It Matter?

Gerhard Coetzee and Ryan Irvine

JCO Sep 1 2002: 3572–3573. [Full Text] [PDF]

Of What Value Is Uracil/Tegafur Plus Leucovorin to Colorectal Cancer Patients?

Michael Friedman

JCO Sep 1 2002: 3574–3575. [Full Text] [PDF]

Lumping Versus Splitting: The Splitters Take This Round

Craig A. Bunnell and Eric P. Winer

JCO Sep 1 2002: 3576–3577. First published on Jul 9 2002; 10.1200/JCO.2002.06.157. [Full Text] [PDF]

ORIGINAL REPORTS
Lung Cancer
	Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial
	Paris Kosmidis, Nick Mylonakis, Costas Nicolaides, Charalabos Kalophonos, Epaminontas Samantas, John Boukovinas, George Fountzilas, Dimosthenis Skarlos, Theophanis Economopoulos, Dimitrios Tsavdaridis, Pavlos Papakostas, Charalabos Bacoyiannis, and Meletios Dimopoulos
	JCO Sep 1 2002: 3578–3585. [Abstract] [Full Text] [PDF]

Sarcomas
	Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma Protuberans
	Brian P. Rubin, Scott M. Schuetze, Janet F. Eary, Thomas H. Norwood, Sohail Mirza, Ernest U. Conrad, and James D. Bruckner
	JCO Sep 1 2002: 3586–3591. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Lack of Effect of a Low-Fat, High-Fruit, -Vegetable, and -Fiber Diet on Serum Prostate-Specific Antigen of Men Without Prostate Cancer: Results From a Randomized Trial
	Moshe Shike, Lianne Latkany, Elyn Riedel, Martin Fleisher, Arthur Schatzkin, Elaine Lanza, Donald Corle, and Colin B. Begg
	JCO Sep 1 2002: 3592–3598. [Abstract] [Full Text] [PDF]
	Racial Variation in CAG Repeat Lengths Within the Androgen Receptor Gene Among Prostate Cancer Patients of Lower Socioeconomic Status
	Charles L. Bennett, Douglas K. Price, Simon Kim, Dachao Liu, Borko D. Jovanovic, Derek Nathan, Margaret E. Johnson, Jeffrey S. Montgomery, Kelly Cude, Justin C. Brockbank, Oliver Sartor, and William D. Figg
	JCO Sep 1 2002: 3599–3604. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Multicenter Phase III Study of Uracil/Tegafur and Oral Leucovorin Versus Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer
	Jean-Yves Douillard, Paulo M. Hoff, Jamey R. Skillings, Peter Eisenberg, Neville Davidson, Peter Harper, Mark D. Vincent, Barry C. Lembersky, Seth Thompson, Antonella Maniero, and Steven E. Benner
	JCO Sep 1 2002: 3605–3616. First published on Jul 9 2002; 10.1200/JCO.2002.04.123. [Abstract] [Full Text] [PDF]
	Randomized Comparative Study of Tegafur/Uracil and Oral Leucovorin Versus Parenteral Fluorouracil and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer
	James Carmichael, Tadeusz Popiela, David Radstone, Stephen Falk, Markus Borner, Amit Oza, Torben Skovsgaard, Stephane Munier, and Christophe Martin
	JCO Sep 1 2002: 3617–3627. [Abstract] [Full Text] [PDF]

Breast Cancer
	Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
	S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald Berry, Kirby I. Bland, Patrick I. Borgen, Gary Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, Robert V.P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann Thor, Donald L. Weaver, H. Samuel Wieand, and Frederick L. Greene
	JCO Sep 1 2002: 3628–3636. First published on Jul 9 2002; 10.1200/JCO.2002.02.026. [Abstract] [Full Text] [PDF]
	Dose-Dense Anthracycline-Based Chemotherapy for Node-Positive Breast Cancer
	Georgiana K. Ellis, Robert B. Livingston, Julie R. Gralow, Stephanie J. Green, and Tove Thompson
	JCO Sep 1 2002: 3637–3643. [Abstract] [Full Text] [PDF]

Brain Tumors
	Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases
	D. Antonadou, M. Paraskevaidis, G. Sarris, N. Coliarakis, I. Economou, P. Karageorgis, and N. Throuvalas
	JCO Sep 1 2002: 3644–3650. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Correlation of Smoking History and Other Patient Characteristics With Major Complications of Pelvic Radiation Therapy for Cervical Cancer
	Patricia J. Eifel, Anuja Jhingran, Diane C. Bodurka, Charles Levenback, and Howard Thames
	JCO Sep 1 2002: 3651–3657. [Abstract] [Full Text] [PDF]

Palliative Care
	Palliative Chemotherapy or Watchful Waiting? A Vignettes Study Among Oncologists
	C.G. Koedoot, J.C.J.M. de Haes, S.H. Heisterkamp, P.J.M. Bakker, A. de Graeff, and R.J. de Haan
	JCO Sep 1 2002: 3658–3664. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Prospective Exploratory Analysis of the Association Between Tumor Response, Quality of Life, and Expenditures Among Patients Receiving Paclitaxel Monotherapy for Refractory Metastatic Breast Cancer
	Shanu Modi, Katherine S. Panageas, Elaine T. Duck, Ariadne Bach, Nancy Weinstock, James Dougherty, Laura Cramer, Clifford Hudis, Larry Norton, and Andrew Seidman
	JCO Sep 1 2002: 3665–3673. [Abstract] [Full Text] [PDF]
	Communication in End-of-Life Cancer Care: A Comparison of Team Assessments in Three European Countries
	Irene J. Higginson and Massimo Costantini
	JCO Sep 1 2002: 3674–3682. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies
	Boon-Cher Goh, Soo-Chin Lee, Ling-Zhi Wang, Lu Fan, Jia-Yi Guo, Jatinder Lamba, Erin Schuetz, Robert Lim, Hong-Liang Lim, Ai-Bee Ong, and How-Sung Lee
	JCO Sep 1 2002: 3683–3690. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Molecular Biology of Anaplastic Lymphoma Kinase–Positive Anaplastic Large-Cell Lymphoma
	Jeffery L. Kutok and Jon C. Aster
	JCO Sep 1 2002: 3691–3702. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy
	John M. Kirkwood, Catherine Bender, Sanjiv Agarwala, Ahmad Tarhini, Janice Shipe-Spotloe, Barbara Smelko, Sandra Donnelly, and Lori Stover
	JCO Sep 1 2002: 3703–3718. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
	James R. Berenson, Bruce E. Hillner, Robert A. Kyle, Ken Anderson, Allan Lipton, Gary C. Yee, and J. Sybil Biermann
	JCO Sep 1 2002: 3719–3736. First published on Jul 1 2002; 10.1200/JCO.2002.06.037. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Hematologic Malignancies: Case 1. Hematologic Malignancy Presenting With Diarrhea and Bony Lesions: Systemic Mastocytosis

Jianguo Tao, Keith Flaherty, and Adam Bagg

JCO Sep 1 2002: 3737–3739. [Full Text] [PDF]

Unusual Hematologic Malignancies: Case 2. Mediastinal Germ Cell Tumor, Malignant Histiocytosis, and Acute Leukemia

Ulka Vaishampayan and Maria E. Dan

JCO Sep 1 2002: 3739–3742. [Full Text] [PDF]

Unusual Hematologic Malignancies: Case 3. CNS Involvement in CD56-Positive Intestinal Gamma/Delta T-Cell Lymphoma

C.S. Chim, C.C.K. Lam, J.M. Nicholls, G.C. Ooi, and Y.L. Kwong

JCO Sep 1 2002: 3742–3744. [Full Text] [PDF]

ART OF ONCOLOGY

House Calls by Oncologists: A Home-Visit Primer

Anand B. Karnad

JCO Sep 1 2002: 3745–3746. [Full Text] [PDF]

SPECIAL DEPARTMENTS

CORRESPONDENCE

Reversible Pancytopenia Caused by Oral Letrozole Assumption in a Patient With Recurrent Breast Cancer

Paola Sperone, Gabriella Gorzegno, Alfredo Berruti, Ubaldo Familiari, and Luigi Dogliotti

JCO Sep 1 2002: 3747–3748. [Full Text] [PDF]

Anastrozole Versus Tamoxifen as First-Line Therapy For Advanced Breast Cancer: Methodologic Issues

Eric Winquist, Vivien Bramwell, Theodore Vandenberg, Jacques Bonneterre, Jean-Marc Nabholtz, Aman Budzar, John Robertson, Beat Thürlimann, Mark Steinberg, Alan Webster, and Mikael von Euler

JCO Sep 1 2002: 3748–3750. [Full Text] [PDF]

Eniluracil’s Need for a Targeted Approach: A Lesson in Drug Development

Michael Castro

JCO Sep 1 2002: 3750. [Full Text] [PDF]

Cost-Effectiveness of Chemotherapy in Non–Small-Cell Lung Cancer

Selin Saglam, Begüm Yetis, Ozgür Ozyilkan, Zafer Akçali, Natasha B. Leighl, Frances A. Shepherd, and Pamela J. Goodwin

JCO Sep 1 2002: 3750-a–3752. [Full Text] [PDF]

Estrogen Receptor-Beta Expression in Hereditary Breast Cancer

Maria Grazia Daidone, Silvia Veneroni, Vera Cappelletti, Paolo Radice, Marco A. Pierotti, Mamoun Younes, Lauren Scheuer, Noah D. Kauff, Mark E. Robson, and Kenneth Offit

JCO Sep 1 2002: 3752–3753. [Full Text] [PDF]

Oxaliplatin: Bimonthly, Biweekly, or Semimonthly? No, Fortnightly!

Matthew T. Seymour

JCO Sep 1 2002: 3753. [Full Text] [PDF]

ERRATA

JCO Sep 1 2002: 3754. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.